安定同位体標識化合物市場- 世界の産業規模、シェア、動向、機会、予測、2018-2028年

世界の安定同位体標識化合物市場は、予測期間2024-2028年に大きな成長が見込まれています。

安定同位体は、汚染物質の発生源の追跡や気候変動の研究など、環境研究で広く使用されています。環境研究の需要の高まりは、安定同位体標識化合物市場の成長を促進すると予想されます。例えば、安定同位体標識化合物は、炭素循環や人間活動が環境に与える影響の研究に使用されています。環境研究の需要が増え続けていることから、安定同位体標識化合物の需要は伸びると予想されます。

新薬と治療薬への需要の増加

がん、心血管疾患、糖尿病などの慢性疾患の増加により、新薬や治療薬に対する需要は絶えず増加しています。世界保健機関（WHO）によると、がんは世界全体の死因の主要因であり、2020年には約1,000万人、つまり死亡者の約6人に1人ががんで死亡することになります。最も多いがんは、肺がん、乳がん、結腸・直腸がん、前立腺がんです。2022年に発表された米国がん協会報告書のデータによると、米国では2022年に191万人以上のがん患者が新たに発生しました。それぞれ395,600人と343,040人が新たに罹患し、生殖器系と消化器系の悪性腫瘍ががん罹患の大部分を占めると予想されています。2021年8月にPubMedが発表したデータによると、安定同位体トレーシングは、栄養補助食品ががんの代謝に影響を与え、標的とする分子メカニズムを理解する上で極めて重要な方法です。

安定同位体で標識された化合物は、研究者が比類のない精度で薬物代謝と潜在的毒性を研究することを可能にします。標識化合物を薬剤候補に入れることで、科学者はその分解を追跡し、代謝物を同定することができます。この知識は、薬物-薬物相互作用の予測、潜在的な副作用の評価、バイオアベイラビリティを改善し毒性を低減した薬物の設計において極めて重要です。

さらに、安定同位体で標識された化合物は、人体における薬物の吸収、分布、代謝、排泄（ADME）に関する貴重な知見を提供します。薬剤開発中に標識化合物を導入することで、研究者はその運命を追跡し、代謝経路を解明し、薬剤のクリアランス効率を評価することができます。この情報は、薬物投与量の最適化、潜在的な副作用の最小化、全体的な薬物の安全性の向上に役立ちます。

安定同位体標識化合物は、炭素-13、窒素-15、酸素-18のような1つ以上の安定同位体を化学構造に組み込んだ合成分子です。

創薬や医薬品開発に安定同位体標識化合物を用いることには、いくつかの利点があります。第一に、安定同位体は非放射性であるため、取り扱いや実験での使用がより安全です。第二に、安定同位体は非標識化合物と化学的に同一であるため、生体系における挙動が同じです。このため、研究者は薬物の体への影響をより正確に研究することができます。最後に、安定同位体標識は、体内での薬物の運命を追跡するユニークな方法を提供し、これは薬物動態の理解と投与量の最適化に不可欠です。

安定同位体標識化合物は、新薬の薬物動態と毒性を調べる前臨床試験にも使用されます。これらの研究は、新薬の規制当局の承認を得るために不可欠です。

プロテオミクスとメタボロミクスへの関心の高まり

プロテオミクスとメタボロミクスは、生命科学の分野で急速に発展している2つの分野で、生物学的システムの理解に革命をもたらし、幅広い疾患に対する新しい治療法を開発する可能性を秘めています。これらの分野は、安定同位体標識化合物の使用に大きく依存しています。安定同位体標識化合物とは、炭素13、窒素15、酸素18などの1つ以上の安定同位体を化学構造に組み込んだ合成分子のことです。プロテオミクスとメタボロミクスへの関心の高まりが、安定同位体標識化合物市場の世界の成長を後押ししています。例えば、安定同位体標識化合物は、Stable Isotope Labeling with Amino Acids in Cell Culture（SILAC）やIsotope-Coded Affinity Tag（ICAT）などの安定同位体標識技術の一部です。安定同位体標識は、タンパク質の機能性と制御に不可欠な翻訳後修飾（PTM）の研究においても重要な役割を果たしています。プロテオミクスはプロテオームの研究であり、細胞、組織、または生物によって産生されるタンパク質全体の集合です。プロテオミクス調査には、タンパク質の同定、定量化、特性解析、およびタンパク質と他の分子との相互作用が含まれます。プロテオミクス研究は、疾患の根底にある分子メカニズムに関する洞察を提供し、医薬品開発のための新たなターゲットを特定することができます。プロテオミクス研究では、安定同位体標識化合物を用いて、タンパク質のターンオーバー、タンパク質間相互作用、タンパク質の局在を研究します。

メタボロミクスとは、細胞、組織、または生物によって産生される小分子の集合体であるメタボローム全体を研究することです。メタボロミクス研究では、代謝物の同定、定量、特性解析、および他の分子との相互作用が行われます。メタボロミクス研究では、代謝フラックス、代謝経路、代謝制御の研究に安定同位体標識化合物が使用されます。

安定同位体標識化合物は、多くのプロテオミクスおよびメタボロミクスアプリケーションに不可欠です。例えば、安定同位体標識アミノ酸は、異なるサンプル間のタンパク質発現レベルを比較する定量プロテオミクス実験に使用されます。安定同位体で標識された脂質や炭水化物は、代謝経路や代謝フラックスを研究するメタボロミクス実験で使用されます。安定同位体で標識されたヌクレオチドは、核酸配列決定実験に使用され、精度の向上とエラーの低減に役立っています。

個別化医療や精密医療への関心の高まりも、世界の安定同位体標識化合物市場の成長を後押ししています。個別化医療と精密医療は、個人の遺伝的体質、ライフスタイル、環境に合わせた治療法を開発することを目的としています。プロテオミクスとメタボロミクスの研究は、個別化医療と精密医療の治療法を開発するための貴重な情報を提供することができます。安定同位体標識化合物は、こうした用途の多くに不可欠です。

技術の進歩

技術の進歩は多くの産業の成長を牽引しており、世界の安定同位体標識化合物市場も例外ではないです。

安定同位体標識化合物市場の成長を牽引する主な技術進歩の1つは、新しい標識技術の開発です。同位体交換や化学合成といった従来の標識技術は、時間とコストがかかり、特殊な装置を必要とします。しかし、代謝標識、酵素標識、生物直交標識などの新しい標識技術は、より効率的でコスト効率が高く、幅広い用途に使用できます。

代謝標識は、アミノ酸、ヌクレオチド、糖などの安定同位体標識前駆体を生きた細胞や生物に取り込む技術です。これらの前駆体をタンパク質、核酸、その他の生体分子に組み込むことで、生体内で安定同位体標識化合物を生産することができます。代謝標識は、代謝経路、タンパク質のターンオーバー、タンパク質間相互作用を研究するための強力な技術です。

酵素標識は、酵素を使って安定同位体標識基質を特定の生体分子に選択的に組み込む技術です。例えば、プロテアーゼ酵素を用いて、安定同位体で標識したアミノ酸を特定のタンパク質に選択的に組み込むことで、部位特異的に標識したタンパク質を生産することができます。酵素標識は、タンパク質の機能、タンパク質間相互作用、翻訳後修飾を研究するための強力な技術です。

生物直交性標識は、生体分子を選択的に標識するために非天然の化学反応を用いる技術です。例えば、安定同位体で標識された糖を特定の糖タンパク質に選択的に組み込むためにバイオorthogonal反応を用いることができ、部位特異的に標識された糖タンパク質の生産が可能になります。バイオルトゴナル標識は、糖タンパク質のような複雑な生体分子を研究し、新しい診断薬や治療薬を開発するための強力な技術です。

世界の安定同位体標識化合物市場の成長を牽引するもう一つの技術的進歩は、新しい分析技術の開発です。質量分析や核磁気共鳴（NMR）分光法などの分析技術は、安定同位体標識化合物や他の分子との相互作用の分析に不可欠です。高分解能質量分析法やNMR分光法などの新しい分析技術の採用により、高品質、ハイスループット、高分解能の安定同位体標識化合物の製造が可能になりつつあります。

高分解能質量分析は、安定同位体標識化合物の質量電荷比を正確に測定するために使用できる技術であり、これらの化合物の同定と定量を可能にします。高分解能質量分析は、タンパク質の発現、代謝経路、代謝フラックスを研究するための強力な手法です。

核磁気共鳴分光法は、安定同位体標識化合物の三次元構造および他の分子との相互作用を決定するために使用できる技術です。NMR分光法は、タンパク質-タンパク質相互作用、タンパク質-リガンド相互作用、タンパク質-核酸相互作用を研究するための強力な技術です。

最近の開発

• 2022年10月、オークリッジ国立研究所（ORNL）は、医療を含む様々な産業で使用される同位体を製造する新しい施設の建設に貢献すると発表しました。
• Cambridge Isotope Laboratories Inc.（CIL）とISOtopic Solutionsの協力により、2022年9月、新規の安定同位体標識および非標識Crude Lipid Yeast Extractが利用可能になっています。
• 大塚グループの一員であり、安定同位体および安定同位体標識化学物質の世界の生産者であるケンブリッジ・アイソトープ・ラボラトリーズ社（CIL）により、2021年7月、量子応用のための商業的に入手可能な初の12C濃縮メタン級ガスが発売されました。
• 2020年、ケンブリッジアイソトープラボラトリーズ（CIL）は、医薬品開発用の安定同位体標識化合物の新シリーズの発売を発表しました。この製品群には、イブプロフェンやナプロキセンなど、一般的に使用されている薬剤の重水素標識アナログが含まれ、薬剤の有効性を向上させ、毒性を軽減するように設計されています。これらの化合物は、さまざまな疾患に対する新しい治療薬の開発に応用できる可能性があります。
• 2020年、グラスゴー大学の研究チームは、重要な代謝経路であるクエン酸サイクルの分析用に、新しい安定同位体標識化合物を開発しました。
• 2020年、アイソトープ・テクノロジーズ・ガルヒング（ITG）はドイツがん研究センター（DKFZ）との提携を発表し、がんの診断と治療のための新しい放射性医薬品を開発します。

調査範囲

本レポートでは、世界の安定同位体標識化合物市場を以下のカテゴリーに分類し、さらに業界動向についても詳述している：

安定同位体標識化合物市場、化合物別

• 炭素（13C）
• 窒素（15N）
• 重水素
• 酸素（18O）
• その他

安定同位体標識化合物市場、用途別

• 診断
• 創薬
• イメージング
• 滅菌
• その他

安定同位体標識化合物市場：物質別

• 核酸
• アミノ酸
• 医薬品/代謝産物
• 脂肪酸/脂質
• NMR溶媒
• その他

安定同位体標識化合物市場：適応症別

• 心臓病学
• 神経学
• 炎症
• 代謝性疾患
• その他

安定同位体標識化合物市場：方法別

• 化学
• 細胞培養

安定同位体標識化合物市場：エンドユーザー別

• 製薬・バイオテクノロジー企業
• 学術機関
• その他

安定同位体標識化合物市場：地域別

• アジア太平洋
  • 中国
  • インド
  • 日本
  • 韓国
  • オーストラリア
• 欧州
  • フランス
  • ドイツ
  • 英国
  • イタリア
  • スペイン
• 北米
  • 米国
  • メキシコ
  • カナダ
• 南米
  • ブラジル
  • アルゼンチン
  • コロンビア
• 中東＆アフリカ
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

競合情勢

企業プロファイル：世界の安定同位体標識化合物市場に参入している主要企業の詳細分析

利用可能なカスタマイズ：

TechSci Research社は、所定の市場データを用いて、企業固有のニーズに応じたカスタマイズを提供します。レポートでは以下のカスタマイズが可能です：

企業情報

• 追加市場参入企業（最大5社）の詳細分析とプロファイリング

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 安定同位体標識化合物の世界市場展望

• 市場規模・予測
  • 金額別
• 市場シェアと予測
  • 化合物別（炭素、窒素、重水素、酸素、その他）
  • 用途別（診断、創薬、イメージング、滅菌、その他）
  • 物質別（核酸、アミノ酸、薬物/代謝物、脂肪酸/脂質、NMR溶媒、その他）
  • 適応症別（循環器、神経、炎症、代謝性疾患、その他）
  • 方法別（化学、細胞培養）
  • エンドユーザー別（製薬・バイオテクノロジー企業、学術機関、その他）
  • 地域別
  • 企業別（2022年）
• 市場マップ
  • 化合物別
  • 用途別
  • 物質別
  • 適応症別
  • 方法別
  • エンドユーザー別

第6章 アジア太平洋安定同位体標識化合物市場展望

• 市場規模・予測
  • 金額別
• 市場シェアと予測
  • 化合物別（窒素、重水素、酸素、その他）
  • 用途別
  • 物質別
  • 適応症別
  • 方法別
  • エンドユーザー別
  • 国別
• アジア太平洋地域国別分析
  • 中国
  • インド
  • 日本
  • 韓国
  • オーストラリア

第7章 欧州安定同位体標識化合物市場展望

• 市場規模・予測
  • 金額別
• 市場シェアと予測
  • 化合物別
  • 用途別
  • 物質別
  • 適応症別
  • 方法別
  • エンドユーザー別
  • 国別
• 欧州国別分析
  • フランス
  • ドイツ
  • 英国
  • イタリア
  • スペイン

第8章 北米安定同位体標識化合物市場の展望

• 市場規模・予測
  • 金額別
• 市場シェアと予測
  • 化合物別
  • 用途別
  • 物質別
  • 適応症別
  • 方法別
  • エンドユーザー別
  • 国別
• 北米国別分析
  • 米国
  • メキシコ
  • カナダ

第9章 南米：安定同位体標識化合物市場の展望

• 市場規模・予測
  • 金額別
• 市場シェアと予測
  • 化合物別
  • 用途別
  • 物質別
  • 適応症別
  • 方法別
  • エンドユーザー別
  • 国別
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカ安定同位体標識化合物市場の展望

• 市場規模・予測
  • 金額別
• 市場シェアと予測
  • 化合物別
  • 用途別
  • 物質別
  • 適応症別
  • 方法別
  • エンドユーザー別
  • 国別
• MEA：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

• 合併と買収
• 製品発表
• 技術の進歩

第13章 競合情勢

• Business Overview
• Company Snapshot
• Products & Services
• Financials（As Reported）
• Recent Developments
• SWOT Analysis
  • PerkinElmer Inc.
  • Merck KGaA
  • 3M Company
  • Cambridge Isotope Laboratories, Inc.
  • JSC Isotope
  • Creative Proteomics
  • Medical Isotopes, Inc.
  • Omicron Biochemicals, Inc.
  • Trace Sciences International
  • Nippon Sanso Holdings Corporation

第14章 戦略的提言

Global stable isotopes labeled compounds market is expected to grow at a significant rate during the forecast period 2024-2028. Stable isotopes are extensively used in environmental studies, such as tracing the sources of pollutants and studying climate change. The growing demand for environmental studies is expected to drive the growth of the stable isotopes labeled compounds market. For example, stable isotope labeled compounds are used to study the carbon cycle and the impact of human activities on the environment. As the demand for environmental studies continues to increase, the demand for stable isotopes labeled compounds is expected to grow.

Stable isotopes are non-radioactive isotopes that have the same number of protons but different numbers of neutrons in their atomic nuclei. They are used extensively in a wide range of scientific and industrial applications, including research, medicine, agriculture, and environmental studies. Stable isotopes labeled compounds are synthetic molecules that incorporate one or more stable isotopes, often carbon-13, nitrogen-15, and oxygen-18, into their chemical structure. These labeled compounds are used to investigate metabolic pathways, study protein-protein interactions, and develop new drugs, which will propel the global stable isotopes labeled compounds market.

Increasing Demand for New Drugs and Therapies

The demand for new drugs and therapies is constantly increasing, driven by the rising prevalence of chronic diseases such as cancer, cardiovascular diseases, and diabetes. According to the World Health Organization (WHO), cancer is a major factor for the cause of death across the world, accounting for approximately 10 million deaths in 2020, or about one in six deaths. The most common cancers are lung, breast, colon and rectum, and prostate cancers. There were over 1.91 million new cancer cases in the United States in 2022, according to data from the American Cancer Society report, publsihed in 2022. With 395,600 and 343,040 new cases, respectively, it is anticipated that malignancies of the genital and digestive systems will account for the majority of cancer cases. Stable isotope tracing is a crucial method for understanding the molecular mechanisms by which nutraceuticals affect and target cancer metabolism, according to data that was published by PubMed in August 2021.

Stable isotopes labeled compounds enable researchers to study drug metabolism and potential toxicity with unparalleled precision. By putting a labeled compound into a drug candidate, scientists can track its breakdown and identify metabolites. This knowledge is crucial in predicting drug-drug interactions, evaluating potential adverse effects, and designing drugs with improved bioavailability and reduced toxicity.

Moreover, stable isotopes labeled compounds offer valuable insights into the absorption, distribution, metabolism, and excretion (ADME) of drugs in the human body. By introducing a labeled compound during drug development, researchers can track its fate, elucidate metabolic pathways, and assess the efficiency of drug clearance. This information aids in optimizing drug dosage, minimizing potential side effects, and improving overall drug safety.

Stable isotope labeled compounds are synthetic molecules that incorporate one or more stable isotopes, such as carbon-13, nitrogen-15, and oxygen-18, into their chemical structure.

The use of stable isotope labeled compounds in drug discovery and development has several advantages. Firstly, stable isotopes are non-radioactive, which makes them safer to handle and use in experiments. Secondly, stable isotopes are chemically identical to their non-labeled counterparts, which means that their behavior in biological systems is the same. This allows researchers to study the effects of drugs on the body more accurately. Finally, stable isotope labeling provides a unique way to track the fate of a drug in the body, which is essential for understanding its pharmacokinetics and optimizing its dosage.

Stable isotope labeled compounds are also used in preclinical studies to investigate the pharmacokinetics and toxicology of new drugs. These studies are essential for obtaining regulatory approval for new drugs.

Growing Interest in Proteomics and Metabolomics

Proteomics and metabolomics are two rapidly growing fields in life sciences that have the potential to revolutionize our understanding of biological systems and develop new therapies for a wide range of diseases. These fields rely heavily on the use of stable isotope labeled compounds, which are synthetic molecules that incorporate one or more stable isotopes, such as carbon-13, nitrogen-15, and oxygen-18, into their chemical structure. The growing interest in proteomics and metabolomics is driving the growth of the global stable isotopes labeled compounds market, as these compounds play a crucial role in these fields. For example, they are a part of stable isotope labeling techniques, such as Stable Isotope Labeling with Amino Acids in Cell Culture (SILAC) and Isotope-Coded Affinity Tag (ICAT). Stable isotope labeling also plays a crucial role in studying Post-Translational Modifications (PTMs), which are essential for protein functionality and regulation. Proteomics is the study of the proteome, which is the entire set of proteins produced by a cell, tissue, or organism. Proteomics research involves the identification, quantification, and characterization of proteins and their interactions with other molecules. Proteomics research can provide insights into the molecular mechanisms underlying diseases and identify new targets for drug development. Stable isotopes labeled compounds are used in proteomics research to study protein turnover, protein-protein interactions, and protein localization.

Metabolomics is the study of the metabolome, which is the entire set of small molecules produced by a cell, tissue, or organism. Metabolomics research involves the identification, quantification, and characterization of metabolites and their interactions with other molecules. Stable isotopes labeled compounds are used in metabolomics research to study metabolic flux, metabolic pathways, and metabolic regulation.

Stable isotopes labeled compounds are essential for many proteomics and metabolomics applications. For example, stable isotope labeled amino acids are used in quantitative proteomics experiments to compare protein expression levels between different samples. Stable isotope labeled lipids and carbohydrates are used in metabolomics experiments to study metabolic pathways and metabolic flux. Stable isotope labeled nucleotides are used in nucleic acid sequencing experiments to improve accuracy and reduce errors.

The growing interest in personalized medicines and precision medicines is also driving the growth of the global stable isotopes labeled compounds market. Personalized medicine and precision medicine aim to develop treatments that are tailored to an individual's genetic makeup, lifestyle, and environment. Proteomics and metabolomics research can provide valuable information for developing personalized and precision medicine treatments. Stable isotope labeled compounds are essential for many of these applications.

Technological Advancements

Technological advancements are driving the growth of many industries, and the global stable isotopes labeled compounds market is no exception.

One of the key technological advancements driving the growth of the stable isotopes labeled compounds market is the development of new labeling techniques. Traditional labeling techniques, such as isotopic exchange and chemical synthesis, are time-consuming, expensive, and require specialized equipment. However, new labeling techniques, such as metabolic labeling, enzymatic labeling, and biorthogonal labeling, are more efficient, cost-effective, and can be used in a wider range of applications.

Metabolic labeling is a technique that involves incorporating stable isotope labeled precursors, such as amino acids, nucleotides, or sugars, into living cells or organisms. These precursors are then incorporated into proteins, nucleic acids, or other biomolecules, allowing for the production of stable isotope labeled compounds in vivo. Metabolic labeling is a powerful technique for studying metabolic pathways, protein turnover, and protein-protein interactions.

Enzymatic labeling is a technique that involves using enzymes to selectively incorporate stable isotope labeled substrates into specific biomolecules. For example, a protease enzyme can be used to selectively incorporate stable isotope labeled amino acids into specific proteins, allowing for the production of site-specifically labeled proteins. Enzymatic labeling is a powerful technique for studying protein function, protein-protein interactions, and post-translational modifications.

Biorthogonal labeling is a technique that involves using non-natural chemical reactions to selectively label biomolecules. For example, a biorthogonal reaction can be used to selectively incorporate stable isotope labeled sugars into specific glycoproteins, allowing for the production of site-specifically labeled glycoproteins. Biorthogonal labeling is a powerful technique for studying complex biomolecules, such as glycoproteins, and for developing new diagnostic and therapeutic agents.

Another technological advancement driving the growth of the global stable isotopes labeled compounds market is the development of new analytical techniques. Analytical techniques, such as mass spectrometry and nuclear magnetic resonance (NMR) spectroscopy, are essential for analyzing stable isotope labeled compounds and their interactions with other molecules. The adoption of new analytical techniques, such as high-resolution mass spectrometry and NMR spectroscopy, is enabling the production of high-quality, high-throughput, and high-resolution stable isotope labeled compounds.

High-resolution mass spectrometry is a technique that can be used to accurately measure the mass-to-charge ratio of stable isotope labeled compounds, allowing for the identification and quantification of these compounds. High-resolution mass spectrometry is a powerful technique for studying protein expression, metabolic pathways, and metabolic flux.

Nuclear magnetic resonance spectroscopy is a technique that can be used to determine the three-dimensional structure of stable isotope labeled compounds and their interactions with other molecules. NMR spectroscopy is a powerful technique for studying protein-protein interactions, protein-ligand interactions, and protein-nucleic acid interactions.

Recent Developments

• In October 2022, Oak Ridge National Laboratory (ORNL) announced that it would contribute to the construction of new facilities to produce isotopes used in a variety of industries, including medicine.
• The novel stable isotope-labeled and unlabeled Crude Lipid Yeast Extract was made available in September 2022, thanks to a collaboration between Cambridge Isotope Laboratories Inc. (CIL) and ISOtopic Solutions.
• The first commercially accessible 12C-enriched methane-grade gas for quantum applications was released by Cambridge Isotope Laboratories, Inc. (CIL), a member of the Otsuka Group and the world's leading producer of stable isotopes and stable isotope-labeled chemicals, in July 2021.
• In 2020, Cambridge Isotope Laboratories (CIL) announced the launch of a new range of stable isotope labeled compounds for drug development. This range includes deuterium-labeled analogs of commonly used drugs, such as ibuprofen and naproxen, which are designed to improve drug efficacy and reduce toxicity. These compounds have potential applications in the development of new therapeutics for a range of diseases.
• In 2020, a team of researchers from the University of Glasgow developed a new stable isotope labeled compound for the analysis of the citric acid cycle, a key metabolic pathway.
• In 2020, Isotope Technologies Garching (ITG) announced a partnership with the German Cancer Research Center (DKFZ) to develop new radiopharmaceuticals for cancer diagnosis and treatment.

Market Segmentation

The global stable isotopes labeled compounds market is segmented by compounds, application, substances, indication, method, end-user, region and company. Based on compounds, the market can be segmented into carbon (13C), nitrogen(15N), deuterium, oxygen(18O), and others. On the basis of application, the market can be categorized as diagnosis, drug discovery, imaging, sterilization, and others. Based on substances, the market can be fragmented into nucleic acids, amino acids, drugs/metabolites, fatty acids /lipids, NMR solvents and others. On the basis of indication, the market can be further segmented into cardiology, neurology, inflammation, metabolic disease, and others. Based on method, the market can be split into chemical and cell-culturing. On the basis of end-user, the market can be categorized into pharmaceutical and biotechnology companies, academic institutes, and others.

Market Players

Major players of the global stable isotopes labeled compounds market include PerkinElmer Inc., Merck KGaA, 3M Company, Cambridge Isotope Laboratories, Inc., JSC Isotope, Creative Proteomics, Medical Isotopes, Inc., Omicron Biochemicals, Inc., Trace Sciences International, and Nippon Sanso Holdings Corporation.

Report Scope:

In this report, global stable isotopes labeled compounds market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

Stable Isotopes Labeled Compounds Market, By Compounds:

• Carbon (13C)
• Nitrogen(15N)
• Deuterium
• Oxygen(18O)
• Others

Stable Isotopes Labeled Compounds Market, By Application:

• Diagnosis
• Drug Discovery
• Imaging
• Sterilization
• Others

Stable Isotopes Labeled Compounds Market, By Substances:

• Nucleic Acids
• Amino Acids
• Drugs/Metabolites
• Fatty Acids/Lipids
• NMR Solvents
• Others

Stable Isotopes Labeled Compounds Market, By Indication:

• Cardiology
• Neurology
• Inflammation
• Metabolic Disease
• Others

Stable Isotopes Labeled Compounds Market, By Method:

• Chemical
• Cell-culturing

Stable Isotopes Labeled Compounds Market, By End-User:

• Pharmaceutical and Biotechnology Companies
• Academic Institute
• Others

Stable Isotopes Labeled Compounds Market, By Region:

• Asia-Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia

• Europe
  • France
  • Germany
  • United Kingdom
  • Italy
  • Spain

• North America
  • United States
  • Mexico
  • Canada

• South America
  • Brazil
  • Argentina
  • Colombia

• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the global stable isotopes labeled compounds market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Stable Isotopes Labeled Compounds Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Compounds (Carbon (13C), Nitrogen(15N), Deuterium, Oxygen(18O), Others)
  • 5.2.2. By Application (Diagnosis, Drug Discovery, Imaging, Sterilization, Others)
  • 5.2.3. By Substances (Nucleic Acids, Amino Acids, Drugs/Metabolites, Fatty Acids /Lipids, NMR Solvents and Others)
  • 5.2.4. By Indication (Cardiology, Neurology, Inflammation, Metabolic disease and Others)
  • 5.2.5. By Method (Chemical, Cell-culturing)
  • 5.2.6. By End-User (Pharmaceutical and Biotechnology Companies, Academic Institute and Others)
  • 5.2.7. By Region
  • 5.2.8. By Company (2022)
• 5.3. Market Map
  • 5.3.1. By Compounds
  • 5.3.2. By Application
  • 5.3.3. By Substances
  • 5.3.4. By Indication
  • 5.3.5. By Method
  • 5.3.6. By End-User

6. Asia-Pacific Stable Isotopes Labeled Compounds Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Compounds (Carbon (13C), Nitrogen(15N), Deuterium, Oxygen(18O), Others)
  • 6.2.2. By Application (Diagnosis, Drug Discovery, Imaging, Sterilization, Others)
  • 6.2.3. By Substances (Nucleic Acids, Amino Acids, Drugs/Metabolites, Fatty Acids /Lipids, NMR Solvents and Others)
  • 6.2.4. By Indication (Cardiology, Neurology, Inflammation, Metabolic disease and Others)
  • 6.2.5. By Method (Chemical, Cell-culturing)
  • 6.2.6. By End-User (Pharmaceutical and Biotechnology Companies, Academic Institute and Others)
  • 6.2.7. By Country
• 6.3. Asia-Pacific: Country Analysis
  • 6.3.1. China Stable Isotopes Labeled Compounds Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Compounds
      • 6.3.1.2.2. By Application
      • 6.3.1.2.3. By Substances
      • 6.3.1.2.4. By Indication
      • 6.3.1.2.5. By Method
      • 6.3.1.2.6. By End-User
  • 6.3.2. India Stable Isotopes Labeled Compounds Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Compounds
      • 6.3.2.2.2. By Application
      • 6.3.2.2.3. By Substances
      • 6.3.2.2.4. By Indication
      • 6.3.2.2.5. By Method
      • 6.3.2.2.6. By End-User
  • 6.3.3. Japan Stable Isotopes Labeled Compounds Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Compounds
      • 6.3.3.2.2. By Application
      • 6.3.3.2.3. By Substances
      • 6.3.3.2.4. By Indication
      • 6.3.3.2.5. By Method
      • 6.3.3.2.6. By End-User
  • 6.3.4. South Korea Stable Isotopes Labeled Compounds Market Outlook
    • 6.3.4.1. Market Size & Forecast
      • 6.3.4.1.1. By Value
    • 6.3.4.2. Market Share & Forecast
      • 6.3.4.2.1. By Compounds
      • 6.3.4.2.2. By Application
      • 6.3.4.2.3. By Substances
      • 6.3.4.2.4. By Indication
      • 6.3.4.2.5. By Method
      • 6.3.4.2.6. By End-User
  • 6.3.5. Australia Stable Isotopes Labeled Compounds Market Outlook
    • 6.3.5.1. Market Size & Forecast
      • 6.3.5.1.1. By Value
    • 6.3.5.2. Market Share & Forecast
      • 6.3.5.2.1. By Compounds
      • 6.3.5.2.2. By Application
      • 6.3.5.2.3. By Substances
      • 6.3.5.2.4. By Indication
      • 6.3.5.2.5. By Method
      • 6.3.5.2.6. By End-User

7. Europe Stable Isotopes Labeled Compounds Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Compounds (Carbon (13C), Nitrogen(15N), Deuterium, Oxygen(18O), Others)
  • 7.2.2. By Application (Diagnosis, Drug Discovery, Imaging, Sterilization, Others)
  • 7.2.3. By Substances (Nucleic Acids, Amino Acids, Drugs/Metabolites, Fatty Acids /Lipids, NMR Solvents and Others)
  • 7.2.4. By Indication (Cardiology, Neurology, Inflammation, Metabolic Disease and Others)
  • 7.2.5. By Method (Chemical, Cell-culturing)
  • 7.2.6. By End-User (Pharmaceutical and Biotechnology Companies, Academic Institute and Others)
  • 7.2.7. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Stable Isotopes Labeled Compounds Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Compounds
      • 7.3.1.2.2. By Application
      • 7.3.1.2.3. By Substances
      • 7.3.1.2.4. By Indication
      • 7.3.1.2.5. By Method
      • 7.3.1.2.6. By End-User
  • 7.3.2. Germany Stable Isotopes Labeled Compounds Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Compounds
      • 7.3.2.2.2. By Application
      • 7.3.2.2.3. By Substances
      • 7.3.2.2.4. By Indication
      • 7.3.2.2.5. By Method
      • 7.3.2.2.6. By End-User
  • 7.3.3. United Kingdom Stable Isotopes Labeled Compounds Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Compounds
      • 7.3.3.2.2. By Application
      • 7.3.3.2.3. By Substances
      • 7.3.3.2.4. By Indication
      • 7.3.3.2.5. By Method
      • 7.3.3.2.6. By End-User
  • 7.3.4. Italy Stable Isotopes Labeled Compounds Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Compounds
      • 7.3.4.2.2. By Application
      • 7.3.4.2.3. By Substances
      • 7.3.4.2.4. By Indication
      • 7.3.4.2.5. By Method
      • 7.3.4.2.6. By End-User
  • 7.3.5. Spain Stable Isotopes Labeled Compounds Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Compounds
      • 7.3.5.2.2. By Application
      • 7.3.5.2.3. By Substances
      • 7.3.5.2.4. By Indication
      • 7.3.5.2.5. By Method
      • 7.3.5.2.6. By End-User

8. North America Stable Isotopes Labeled Compounds Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Compounds (Carbon (13C), Nitrogen(15N), Deuterium, Oxygen(18O), Others)
  • 8.2.2. By Application (Diagnosis, Drug Discovery, Imaging, Sterilization, Others)
  • 8.2.3. By Substances (Nucleic Acids, Amino Acids, Drugs/Metabolites, Fatty Acids /Lipids, NMR Solvents and Others)
  • 8.2.4. By Indication (Cardiology, Neurology, Inflammation, Metabolic disease and Others)
  • 8.2.5. By Method (Chemical, Cell-culturing)
  • 8.2.6. By End-User (Pharmaceutical and Biotechnology Companies, Academic Institute and Others)
  • 8.2.7. By Country
• 8.3. North America: Country Analysis
  • 8.3.1. United States Stable Isotopes Labeled Compounds Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Compounds
      • 8.3.1.2.2. By Application
      • 8.3.1.2.3. By Substances
      • 8.3.1.2.4. By Indication
      • 8.3.1.2.5. By Method
      • 8.3.1.2.6. By End-User
  • 8.3.2. Mexico Stable Isotopes Labeled Compounds Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Compounds
      • 8.3.2.2.2. By Application
      • 8.3.2.2.3. By Substances
      • 8.3.2.2.4. By Indication
      • 8.3.2.2.5. By Method
      • 8.3.2.2.6. By End-User
  • 8.3.3. Canada Stable Isotopes Labeled Compounds Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Compounds
      • 8.3.3.2.2. By Application
      • 8.3.3.2.3. By Substances
      • 8.3.3.2.4. By Indication
      • 8.3.3.2.5. By Method
      • 8.3.3.2.6. By End-User

9. South America Stable Isotopes Labeled Compounds Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Compounds (Carbon (13C), Nitrogen(15N), Deuterium, Oxygen(18O), Others)
  • 9.2.2. By Application (Diagnosis, Drug Discovery, Imaging, Sterilization, Others)
  • 9.2.3. By Substances (Nucleic Acids, Amino Acids, Drugs/Metabolites, Fatty Acids /Lipids, NMR Solvents and Others)
  • 9.2.4. By Indication (Cardiology, Neurology, Inflammation, Metabolic disease and Others)
  • 9.2.5. By Method (Chemical, Cell-culturing)
  • 9.2.6. By End-User (Pharmaceutical and Biotechnology Companies, Academic Institute and Others)
  • 9.2.7. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Stable Isotopes Labeled Compounds Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Compounds
      • 9.3.1.2.2. By Application
      • 9.3.1.2.3. By Substances
      • 9.3.1.2.4. By Indication
      • 9.3.1.2.5. By Method
      • 9.3.1.2.6. By End-User
  • 9.3.2. Argentina Stable Isotopes Labeled Compounds Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Compounds
      • 9.3.2.2.2. By Application
      • 9.3.2.2.3. By Substances
      • 9.3.2.2.4. By Indication
      • 9.3.2.2.5. By Method
      • 9.3.2.2.6. By End-User
  • 9.3.3. Colombia Stable Isotopes Labeled Compounds Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Compounds
      • 9.3.3.2.2. By Application
      • 9.3.3.2.3. By Substances
      • 9.3.3.2.4. By Indication
      • 9.3.3.2.5. By Method
      • 9.3.3.2.6. By End-User

10. Middle East and Africa Stable Isotopes Labeled Compounds Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Compounds (Carbon (13C), Nitrogen(15N), Deuterium, Oxygen(18O), Others)
  • 10.2.2. By Application (Diagnosis, Drug Discovery, Imaging, Sterilization, Others)
  • 10.2.3. By Substances (Nucleic Acids, Amino Acids, Drugs/Metabolites, Fatty Acids /Lipids, NMR Solvents and Others)
  • 10.2.4. By Indication (Cardiology, Neurology, Inflammation, Metabolic disease and Others)
  • 10.2.5. By Method (Chemical, Cell-culturing)
  • 10.2.6. By End-User (Pharmaceutical and Biotechnology Companies, Academic Institute and Others)
  • 10.2.7. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Stable Isotopes Labeled Compounds Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Compounds
      • 10.3.1.2.2. By Application
      • 10.3.1.2.3. By Substances
      • 10.3.1.2.4. By Indication
      • 10.3.1.2.5. By Method
      • 10.3.1.2.6. By End-User
  • 10.3.2. Saudi Arabia Stable Isotopes Labeled Compounds Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Compounds
      • 10.3.2.2.2. By Application
      • 10.3.2.2.3. By Substances
      • 10.3.2.2.4. By Indication
      • 10.3.2.2.5. By Method
      • 10.3.2.2.6. By End-User
  • 10.3.3. UAE Stable Isotopes Labeled Compounds Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Compounds
      • 10.3.3.2.2. By Application
      • 10.3.3.2.3. By Substances
      • 10.3.3.2.4. By Indication
      • 10.3.3.2.5. By Method
      • 10.3.3.2.6. By End-User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Mergers & Acquisitions
• 12.2. Product Launches
• 12.3. Technological Advancements

13. Competitive Landscape

• 13.1. Business Overview
• 13.2. Company Snapshot
• 13.3. Products & Services
• 13.4. Financials (As Reported)
• 13.5. Recent Developments
• 13.6. SWOT Analysis
  • 13.6.1. PerkinElmer Inc.
  • 13.6.2. Merck KGaA
  • 13.6.3. 3M Company
  • 13.6.4. Cambridge Isotope Laboratories, Inc.
  • 13.6.5. JSC Isotope
  • 13.6.6. Creative Proteomics
  • 13.6.7. Medical Isotopes, Inc.
  • 13.6.8. Omicron Biochemicals, Inc.
  • 13.6.9. Trace Sciences International
  • 13.6.10. Nippon Sanso Holdings Corporation

14. Strategic Recommendations